ACADIA Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio13.48
Forward P/E35.9027.40
P/S Ratio3.197.084.987.7519.24
P/B Ratio4.1711.916.446.9413.55
Price/Tangible Book4.9814.046.446.9413.58
Price/FCF19.42308.70
Price/OCF19.36307.78
Enterprise Value Ratios
EV/Revenue2.656.684.266.7717.89
EV/EBITDA25.33
EV/EBIT30.11
EV/FCF16.14291.36
Profitability & Returns
Return on Equity (ROE)0.39%-0.15%-0.46%-0.29%-0.42%
Return on Assets (ROA)0.05%-0.07%-0.22%-0.14%-0.19%
Return on Invested Capital (ROIC)1.87%-1.53%-3.43%-2.64%-8.33%
Return on Capital Employed (ROCE)0.11%-0.15%-0.48%-0.28%-0.35%
Leverage & Solvency Ratios
Debt/Equity0.070.130.150.120.08
Debt/EBITDA0.47
Debt/FCF0.333.44
Liquidity Ratios
Current Ratio2.382.424.046.436.77
Quick Ratio2.182.133.826.106.44
Efficiency Ratios
Asset Turnover0.991.090.800.650.56
Inventory Turnover13.3318.5351.2229.4435.81
Yield & Distribution Ratios
Earnings Yield0.07%-0.01%-0.08%-0.04%-0.03%
FCF Yield0.05%0.00%-0.04%-0.03%-0.02%
Buyback Yield-0.02%-0.01%-0.01%-0.02%-0.07%